Pharma company Ranbaxy Laboratories today said it will launch a generic version of the urinary disorder treatment drug-- Flomax, next year.
"We will launch a generic version of the urinary disorder treatment Flomax in March 2010," Ranbaxy Laboratories CFO Omesh Sethi told reporters on the sidelines of a seminar here.
"We would launch another big one in 2014," he said, without naming it.
"We are doing well and expect a good revenue from domestic and global markets in the next financial year," Sethi said.
